Association between raised blood pressure and dysglycemia in Hong Kong Chinese

Bernard M Y Cheung1, Nelson M S Wat, Annette W K Tso

  • 1Department of Medicine, University of Hong Kong, Hong Kong, China. b.cheung@bham.ac.uk

Diabetes Care
|June 17, 2008
PubMed

Insights

Raised blood pressure and dysglycemia (diabetes or impaired glucose tolerance) share common risk factors and etiological pathways. Early screening and management for both conditions are recommended to prevent adverse cardiovascular events.

Area of Science:

  • Cardiovascular disease research
  • Metabolic syndrome studies
  • Public health and epidemiology

Background:

  • Hypertension and dysglycemia are significant global health concerns.
  • Both conditions are linked to increased cardiovascular risk.
  • Understanding their shared origins is crucial for effective prevention and treatment.

Purpose of the Study:

  • To examine the relationship between elevated blood pressure and dysglycemia.
  • To identify predictors for the onset of diabetes and hypertension.

Main Methods:

  • Analysis of 1,862 subjects from the Hong Kong Cardiovascular Risk Factor Prevalence Study.
  • Determination of factors predicting new-onset diabetes and hypertension in 1,496 individuals without these conditions at baseline.

Main Results:

  • Diabetes and hypertension were associated with age, obesity, blood pressure, glucose levels, HDL cholesterol, and triglycerides.
  • 58% of individuals with diabetes had elevated blood pressure; 56% with hypertension had dysglycemia.
  • BMI, 2-h glucose, and systolic blood pressure independently predicted the development of diabetes, hypertension, or both.

Conclusions:

  • Diabetes and hypertension share common etiological factors.
  • Screening and management for precursor conditions are advised for patients with either diabetes or hypertension.
  • Integrated management strategies may improve cardiovascular outcomes.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.